Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wilcock

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 8, 2002
Prescribing costs and patternsMichael Wilcock
Drug and Therapeutics Bulletin|August 17, 2024
Medicines optimisation opportunities: driving change?Michael Wilcock
Drug and Therapeutics Bulletin|June 2, 2019
It is hard work being a patientMichael Wilcock
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 7, 2004
CSM thioridazine adviceMichael Wilcock
Drug and Therapeutics Bulletin|January 10, 2024
Limiting drugs prescribed in primary careMichael Wilcock
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 28, 2003
Why do GPs see drug reps?Michael Wilcock
Drug and Therapeutics Bulletin|June 26, 2020
Dilemmas in commissioning biological therapiesMichael Wilcock
Age and Ageing|March 5, 2003
Change in general practitioner prescribingMichael Wilcock
Drug and Therapeutics Bulletin|August 23, 2020
Pharmaceutical marketing-greater than the sum of its parts?Michael Wilcock
Drug and Therapeutics Bulletin|December 21, 2021
Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stopMark Horowitz, Michael Wilcock
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 8, 2002
Prescribing costs and patternsMichael Wilcock
Drug and Therapeutics Bulletin|August 17, 2024
Medicines optimisation opportunities: driving change?Michael Wilcock
Drug and Therapeutics Bulletin|June 2, 2019
It is hard work being a patientMichael Wilcock
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 7, 2004
CSM thioridazine adviceMichael Wilcock
Drug and Therapeutics Bulletin|January 10, 2024
Limiting drugs prescribed in primary careMichael Wilcock
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 28, 2003
Why do GPs see drug reps?Michael Wilcock
Drug and Therapeutics Bulletin|June 26, 2020
Dilemmas in commissioning biological therapiesMichael Wilcock
Age and Ageing|March 5, 2003
Change in general practitioner prescribingMichael Wilcock
Drug and Therapeutics Bulletin|August 23, 2020
Pharmaceutical marketing-greater than the sum of its parts?Michael Wilcock
Drug and Therapeutics Bulletin|December 21, 2021
Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stopMark Horowitz, Michael Wilcock
Pageof 5